期刊文献+

喹硫平与舒必利对精神分裂症患者血脂代谢的影响

Effects of Quetiapine and Sulpiride on serum lipid metabolism in schizophrenic patients
下载PDF
导出
摘要 目的探讨喹硫平和舒必利对精神分裂症患者血脂代谢影响,并比较男女之间的差异。方法 2006年1月至2009年1月期间入院予喹硫平或舒必利治疗的精神分裂症患者453例,分析喹硫平与舒必利治疗8周前后的空腹血胆固醇(TC)、甘油三酯(TG)浓度变化。结果①喹硫平治疗组胆固醇及甘油三酯前后变化不明显,差异均无统计学意义(t=1.45,P=0.13;t=1.58,P=0.10),男女间差异无统计学意义(t=1.03,P=0.28;t=1.34,P=0.16)。②舒必利组治疗后胆固醇及甘油三酯明显升高(t=3.01,P=0.006;t=2.42,P=0.017),且女性胆固醇及甘油三酯升高的程度显著大于男性患者(t=2.46,P=0.019,t=2.13,P=0.034)。③舒必利对胆固醇及甘油三酯的影响程度均大于喹硫平(t=2.69,P=0.008;t=2.08,P=0.021)。结论喹硫平对精神分裂症患者血脂代谢的影响不大;舒必利使血胆固醇及甘油三酯水平升高,且对女性影响大。舒必利对胆固醇及甘油三酯的影响均大于喹硫平。 Objective To explore the effects of Quetiapine and Sulpiride on serum lipid metabolism in male and female patients with schizophrenia. Method 453 schizophrenic patients registered to our hospital between January 2006 and January 2009 were included to receive Quetiapine or Sulpiride treatment. The changes in fasting serum levels of total cholesterol (TC) and triglyceride (TG) after the 8-week treatment with Quetiapine or Sulpiride from baseline were analyzed. Results (1)After Quetiapine treatment, the serum levels of TC and TG (t=l.45,P=0.13;t=l.58,P=0. l0) did not shown any change from baseline or any difference between both genders (t=l.03,p=0.28;t=l.34,P=0.16). (2) After Sulpiride treatment, significant increases in serum levels of TC and TG were shown in the patients (t=3.01 ,P= 0.006 ; t =2.42, P=0.017), especially in females (t =2.46, P=0.019 ; t =2.13, P=0.034); (3) Sulpiride had greater effects on serum TC and TG than Quetiapine (t=2.69,P=O.OO8;t=2.08,P=0.021). Conclusion Quetiapine has little effects on lipid metabolism, while sulpiride induces elevated serum levels of TC and TG, especially in female patients. Sulpiride may have greater effects on serum TC and TG than Quetiapine.
出处 《中国药物与临床》 CAS 2011年第9期1003-1005,共3页 Chinese Remedies & Clinics
基金 200040上海市自然科学基金(10ZR1425700) 上海市卫生局科研项目(2009097)
关键词 精神分裂症 舒必利 喹硫平 血脂 Schizophrenia Sulpiride Quetiapine Blood lipid
  • 相关文献

参考文献15

  • 1Saha S,Chant D,Welham J,et al. A systematic review of the prevalence of schizophrenia. Plos Med, 2005,2 ( 5 ) : 413-433. 被引量:1
  • 2Edward K, Shaloo G, Susan B,et al. Adherence and outcomes as- sociated with copayment borden in schizophrenia: a cross-sec- tional survey. J Med Econ, 2010,13(2):185-192. 被引量:1
  • 3Mehta S,Johnson ML,Chen H, et al. Risk of cerebrovascular ad- verse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiat, 2010,71 (6) :689-698. 被引量:1
  • 4Ren NS, Herz L, Qian, et al. Measurement of treatment adherence with antipsychotic agentsin patients with schizophrenia. Neu- ropsychiatr Dis Treat, 2009,5 : 491-498. 被引量:1
  • 5Ray WA. Both typical and atypical antipsychotic agents were as- sociated with increased risk for sudden cardiac death. Ann Intern Med, 2009,151 (4) :JC2-JC12. 被引量:1
  • 6McIntyre RS, Jerrell JM. Antipsychotic agents and car- diometabolic morbidity in youth reply. Arch Pediat Adol Med, 2009,163(4) :395-395. 被引量:1
  • 7曾宪茂,张华江.奎硫平对体质量及脂代谢的影响[J].临床精神医学杂志,2008,18(5):304-304. 被引量:8
  • 8Goff DC,Cather C,Evins AE,et al. Medical morbidity and mor- tality in schizophrenia: guidelines for psychiatrists. J Clin Psy- chiatry, 2005,66(2) : 183-19. 被引量:1
  • 9唐茂芹,翟杰,黄劲松,王远玉,高新民.喹硫平与舒必利治疗对精神分裂症患者血糖和脂代谢的影响[J].中国心理卫生杂志,2009,23(8):575-578. 被引量:10
  • 10Lindenmayer JP,Nathan AM,Smith RC. Hyperglycemia associat- ed with the use of atypical antipsyehotics. J Clin Psychiatry, 2001,62: 30-37. 被引量:1

二级参考文献19

  • 1韦盛中.奎硫平与舒必利治疗精神分裂症阴性症状对照研究[J].右江民族医学院学报,2006,28(5):767-768. 被引量:2
  • 2张明园.副反应量表[J].上海精神医学,1984,2:77-80. 被引量:10
  • 3McConvilleBJ, AtvanitisLA, ThyrumPT, etal. Pharmacokinetics, tolerability, andclinicaleffectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders [J] .J Clin Psychiatry, 2000, 61:252 -260. 被引量:1
  • 4Arvanitis LA, Miller BG.. Multiple fixed doses of" Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo[J]. Biol Psychiatry, 1997, 42:233 -246. 被引量:1
  • 5Meyer JM. Novel antipsychotics and severe hyperlipidemia [J]. J Clin Psychopharmacol, 2001, 21 : 369 -374. 被引量:1
  • 6Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose doubleblind comparison with placebo [ J ] . Arch Gen psychiatry, 1997, 54: 549-557. 被引量:1
  • 7Green B. Focus on quetiapine [J]. Curr Med Res Opin, 1999, 15:145 -151. 被引量:1
  • 8King DJ. Drug schizophrenia [ J ] . Eur Neuropsychopharmacol, 1998, 8:33-42. 被引量:1
  • 9Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the Positive and negative Syndrome Scale for schizophrenics. Psychiatry Res, 1988, 23 : 99 - 110. 被引量:1
  • 10吴文源.临床疗效总评量表(CGI).上海精神医学,1984,2:76-77. 被引量:7

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部